With respect to pathological conditions, knock-down of GSK3α, but not GSK3β, ameliorated amyloid plaque loads and memory deficits in an Alzheimer’s disease (AD) mouse model [30]. This evidence concerns the gene GSK3B and Alzheimer disease.